Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2012
06/28/2012US20120165358 Controlled release formulations of opioid and nonopioid analgesics
06/28/2012US20120164625 Methods for rapid identification of pathogens in humans and animals
06/28/2012US20120164234 Compositions and methods for separating, characterizing and administering soluble selenoglycoproteins
06/28/2012US20120164233 Pulsatile release pharmaceutical formulation of dexlansoprazole
06/28/2012US20120164232 Construct coated with virus coat-constituting protein and method for producing same
06/28/2012US20120164231 Synthesis Of Oxygen Carrying, Turbulence Resistant, High Density Submicron Particulates
06/28/2012US20120164230 Soluble Nanoparticles as Delivery Systems for Prodrugs
06/28/2012US20120164229 Depot systems comprising glatiramer or pharmacologically acceptable salt thereof
06/28/2012US20120164228 Novel pharmaceutical formulations to prevent the misuse of medicinal drugs
06/28/2012US20120164227 New granulating process and thus prepared granulate
06/28/2012US20120164226 Compositions and Methods for Improving Prognosis of a Human with Subarachnoid Hemorrhage
06/28/2012US20120164225 Bone graft materials and methods
06/28/2012US20120164224 Hemostatic Preparation Containing an Extract of Golden Moss
06/28/2012US20120164223 Rapidly disintegrating, solid coated dosage form
06/28/2012US20120164222 Novel compounds and compositions and methods of use
06/28/2012US20120164221 Combinations of hmg-coa reductase inhibitors and nicotinic acid compounds and methods for treating hyperlipidemia once a day at night
06/28/2012US20120164220 Encased Tamper Resistant Controlled Release Dosage Forms
06/28/2012US20120164219 Peroral tablet for bowel cleansing
06/28/2012US20120164218 Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same
06/28/2012US20120164217 Scented capsules
06/28/2012US20120164216 Pharmaceutical composition of duloxetine or pharmaceutically
06/28/2012US20120164215 Topical co-enzyme q10 formulations and methods of use
06/28/2012US20120164214 Liposomal compositions and uses of same
06/28/2012US20120164213 Time-release and micro-dose formulations for topical application of estrogen and estrogen analogs or other estrogen receptor modulators in the treatment of dry eye syndrome, and methods of preparation and application
06/28/2012US20120164212 Stem cell beacon
06/28/2012US20120164211 Compositions and methods for treating lymphoma
06/28/2012US20120164210 Photodynamic therapeutic agent having cell-specific active accumulation properties
06/28/2012US20120164209 Abuse resistant drugs, method of use and method of making
06/28/2012US20120164208 Chitosan hydrogel derivatives as a coating agent with broad spectrum of antimicrobial activities
06/28/2012US20120164207 Degradable networks for sustained release and controlled release depot drug delivery applications
06/28/2012US20120164200 Substrates comprising frothed benefit agents and the method of making the same
06/28/2012US20120164195 Cosmetic Films
06/28/2012US20120164193 Extended-release formulation for reducing the frequency of urination and method of use thereof
06/28/2012US20120164192 Delayed release formulation for reducing the frequency of urination and method of use thereof
06/28/2012US20120164191 Transmucosal delivery devices with enhanced uptake
06/28/2012US20120164190 Nanoparticle isoflavone compositions & methods of making and using the same
06/28/2012US20120164189 Lipidic Compositions for Induction of Immune Tolerance
06/28/2012US20120164188 Paliperidone or a pharmaceutically acceptable salt thereof substantially free of impurities
06/28/2012US20120164187 bioactive glass for use in conditions relating to bone infections
06/28/2012US20120164186 Diketopiperazine Microparticles with Defined Specific Surface Areas
06/28/2012US20120164185 Oral nutrient or medicant carrier having increased surface area and absorption rate
06/28/2012US20120164184 DPI Formulation Containing Sulfoalkyl Ether Cyclodextrin
06/28/2012US20120164183 Method for detection and treatment of aneurysms
06/28/2012US20120164099 Use of human prostate cell lines in cancer treatment
06/28/2012US20120164080 Methods of treatment for esophageal inflammation
06/28/2012US20120164075 Endoxifen methods and compositions in the treatment of mammalian diseases
06/28/2012US20120164074 Methods of diagnosing, preventing and treating cancer metastasis
06/28/2012US20120164072 Nano-sized particles comprising multi-headed amphiphiles for targeted drug delivery
06/28/2012US20120164069 Compositions and methods for surface abrasion with frozen particles
06/28/2012US20120164065 Method and composition for treating cancer
06/28/2012US20120161346 Method and apparatus for preparing micro-particles of polysaccharides
06/28/2012DE112010003201T5 Beschichtete Sennesextrektpellets Coated Sennesextrektpellets
06/28/2012DE102010056192A1 Kolloidales Trägersystem mit penetrierenden Eigenschaften zum Einschließen lipophiler Wirkstoffe und Öle für die topische Anwendung Colloidal carrier system with penetrating properties to entrap lipophilic active ingredients or oils for topical application
06/28/2012DE102010056029A1 Heat compress useful as heat packs for relieving e.g. mental state disorders, pain, migraine and skeleton degeneration comprises fluid homeopathic composition in casing, skin patch cushion formed by composition and casing, and heat source
06/28/2012CA2822795A1 Novel preparation of an enteric release system
06/28/2012CA2822790A1 Encased tamper resistant controlled release dosage forms
06/28/2012CA2822769A1 Tamper resistant solid oral dosage forms
06/28/2012CA2822738A1 Method and system for drug delivery
06/28/2012CA2822701A1 Novel pharmaceutical composition
06/28/2012CA2822553A1 Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
06/28/2012CA2822547A1 Dermatological foams obtained from a gel or suspension containing benzoyl peroxide
06/28/2012CA2822546A1 Dermatological foams obtained from a gel or suspension containing adapalene
06/28/2012CA2822539A1 Dermatological foams obtained from a gel or suspension containing a combination of adapalene and benzoyl peroxide
06/28/2012CA2822359A1 Enhanced immune response in bovine species
06/28/2012CA2822265A1 Process for the preparation of a pharmaceutical composition comprising a low soluble pharmaceutically active ingredient
06/28/2012CA2822232A1 A drug eluting patch for the treatment of localized tissue disease or defect
06/28/2012CA2822227A1 Fluid compositions comprising a structuring agent
06/28/2012CA2822208A1 Triggered polymer viscous pill and methods of using the same
06/28/2012CA2822088A1 Pharmaceutical composition containing active plant substances
06/28/2012CA2821659A1 Solid retard formulations based on solid dispersions
06/28/2012CA2821382A1 Phosphomycin pharmaceutical composition
06/28/2012CA2821230A1 Pharmaceutical compositions of pyridinium and quinolinium derivatives
06/28/2012CA2820437A1 Pharmaceutical composites of poorly water soluble drugs and polymers
06/28/2012CA2817453A1 Aqueous solution of ambroxol
06/28/2012CA2762340A1 Compositions and methods for treating joints
06/27/2012EP2469285A1 Water soluble metal and semiconductor nanoparticle complexes
06/27/2012EP2468765A1 Multimer of extracellular domain of cell surface functional molecule
06/27/2012EP2468278A1 Controlled release oral formulations of ion channel modulating compounds and related methods for preventing arrhythmia
06/27/2012EP2468274A1 Transdermal therapeutic system for application of an agent
06/27/2012EP2468268A1 Combination composition of vildagliptin and gliclazide
06/27/2012EP2468267A1 Bilayer Combination Composition of Vildagliptin and Gliclazide
06/27/2012EP2468266A2 Pharmaceutical compositions for acute glucocorticoid therapy
06/27/2012EP2468265A2 Homogeneous preparations containing vitamin D
06/27/2012EP2468264A1 Oral pharmaceutical tablet for controled release of mesalazine and process for obtaining it
06/27/2012EP2468263A1 Compressed solid dosage forms
06/27/2012EP2468262A1 Pharmaceutical composition comprising dutasteride
06/27/2012EP2468261A1 Formulation of lacosamide
06/27/2012EP2468260A2 Liposomes covered with the extracellular domain of the apo2l/trail protein
06/27/2012EP2468259A1 Pharmaceutical compositions of pyridinium and quinolinium derivatives
06/27/2012EP2468258A1 Process for the preparation of a pharmaceutical composition comprising a low soluble pharmaceutically active ingredient
06/27/2012EP2468257A2 Injectable composition containing hydroxychloroquine for local administration for treating hemorrhoids
06/27/2012EP2468256A1 Combinations of vildagliptin and glimepiride
06/27/2012EP2468255A2 Biodegradable osmotic pump implant for drug delivery
06/27/2012EP2468254A1 Orally disintegrating tablet having a taste masking effect
06/27/2012EP2468253A1 Terpenoid spiro ketal compounds with LXR agonists activity, their use and formulations with them
06/27/2012EP2468094A1 Composition and methods for modulation of vascular structure and/or function
06/27/2012EP2467715A1 Riboflavin based aerosol and use as placebo in trials
06/27/2012EP2467465A1 Alcoholic compositions having a lowered risk of acetaldehydemia
06/27/2012EP2467425A1 Water-soluble polysaccharide ethers and the use thereof
06/27/2012EP2467357A1 Novel cationic lipids with various head groups for oligonucleotide delivery
1 ... 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 ... 2991